Andrea de Bartolomeis Selected Research

postsynaptic density proteins

1/2017	Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia.
2/2014	Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea de Bartolomeis Research Topics

Disease

50	Schizophrenia (Dementia Praecox) 01/2022 - 01/2002
20	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 04/2007
15	Bipolar Disorder (Manic Depressive Psychosis) 10/2021 - 01/2011
11	Treatment-Resistant Schizophrenia 01/2022 - 05/2012
9	Mental Disorders (Mental Disorder) 01/2022 - 03/2003
6	Mood Disorders (Mood Disorder) 01/2022 - 06/2014
6	Mania (Manias) 11/2020 - 10/2012
6	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 01/2016
6	AIDS-Related Complex (ARC) 01/2018 - 10/2013
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2018 - 10/2012
4	Weight Gain 11/2016 - 10/2007
3	Autism Spectrum Disorder 12/2021 - 02/2014
3	Neurobehavioral Manifestations 10/2019 - 05/2012
3	Obesity 01/2011 - 10/2007
2	Neurodevelopmental Disorders 01/2022 - 11/2020
2	Tic Disorders (Tic Disorder) 12/2021 - 11/2020
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2018 - 01/2015
2	Anxiety Disorders (Anxiety Disorder) 01/2018 - 01/2016
2	Cognitive Dysfunction 01/2016 - 11/2013
2	Depressive Disorder (Melancholia) 10/2012 - 03/2003
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2022
1	Encephalitis (Encephalitis, Rasmussen) 01/2022
1	Epilepsy (Aura) 12/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2020
1	Intellectual Disability (Idiocy) 11/2020
1	Tourette Syndrome (Tourette's Syndrome) 11/2020
1	Dementia (Dementias) 01/2020
1	Weight Loss (Weight Reduction) 10/2019
1	Disease Progression 01/2019
1	Atrial Fibrillation 10/2018
1	Myocardial Infarction 10/2018
1	Hypertension (High Blood Pressure) 10/2018
1	Bronchial Spasm 02/2017
1	Borderline Personality Disorder (Personality Disorders, Borderline) 02/2017
1	Hyperalgesia 01/2016

Drug/Important Bio-Agent (IBA)

43	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2002
15	Glutamic Acid (Glutamate)FDA Link 01/2022 - 10/2010
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2012
10	Antidepressive Agents (Antidepressants)IBA 01/2019 - 03/2003
9	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 10/2012
7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016 - 12/2002
6	Haloperidol (Haldol)FDA LinkGeneric 01/2021 - 03/2003
6	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 01/2011
6	Pharmaceutical PreparationsIBA 02/2017 - 01/2011
5	Ketamine FDA LinkGeneric 01/2017 - 04/2007
4	D-Aspartic Acid (D Aspartate)IBA 01/2022 - 10/2013
4	Clozapine (Clozaril)FDA LinkGeneric 01/2022 - 04/2012
3	Serine (L-Serine)FDA Link 01/2022 - 10/2013
3	Amino Acids FDA Link 01/2022 - 10/2013
3	Biological ProductsIBA 01/2022 - 02/2014
3	Aripiprazole (Abilify)FDA Link 10/2018 - 10/2012
3	Memantine (Namenda)FDA Link 10/2014 - 05/2012
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022 - 10/2013
2	Protein Isoforms (Isoforms)IBA 01/2022 - 04/2006
2	Biomarkers (Surrogate Marker)IBA 11/2018 - 11/2018
2	LithiumIBA 11/2018 - 03/2003
2	postsynaptic density proteinsIBA 01/2017 - 02/2014
2	VortioxetineIBA 11/2016 - 01/2016
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 09/2015 - 11/2013
2	BenzodiazepinesIBA 01/2015 - 03/2003
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2015 - 04/2009
2	N-Methylaspartate (NMDA)IBA 10/2013 - 04/2007
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2004 - 03/2003
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	Bupropion (Wellbutrin)FDA LinkGeneric 01/2022
1	Varenicline (Chantix)FDA Link 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	AmphetaminesIBA 10/2019
1	EndorphinsIBA 10/2019
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2019
1	Growth Hormone (Somatotropin)IBA 10/2019
1	Methylphenidate (Ritalin)FDA LinkGeneric 10/2019
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 10/2019
1	mesoglycanIBA 11/2018
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2018
1	vasectrin II (VS II)IBA 03/2018
1	Caffeine (No Doz)FDA LinkGeneric 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Nicotine FDA Link 01/2018
1	C-Reactive ProteinIBA 08/2017
1	agomelatine (S20098)IBA 08/2017
1	Loxapine (Loxitane)FDA LinkGeneric 02/2017
1	PowdersIBA 02/2017
1	asenapine FDA Link 01/2017
1	Olanzapine (Zyprexa)FDA Link 01/2017
1	PlasticsIBA 01/2017
1	Minocycline (Cyclops)FDA LinkGeneric 01/2017
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2017
1	Lurasidone Hydrochloride FDA Link 01/2017
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2016
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2016
1	Methionine (L-Methionine)FDA Link 01/2016

Therapy/Procedure

11	Therapeutics 01/2022 - 08/2009
5	Transcranial Direct Current Stimulation 12/2021 - 01/2016
3	Drug Therapy (Chemotherapy) 02/2022 - 01/2002
1	Treatment Delay 10/2021
1	Home Nursing (Nursing, Home) 01/2020
1	Aftercare (After-Treatment) 08/2017
1	Injections 01/2016